LIPO - Lipella Pharmaceuticals Inc
2.19
-0.060 -2.740%
Share volume: 43,248
Last Updated: 03-13-2025
Pharmaceutical Products/Pharmaceutical Preparations:
0.01%
PREVIOUS CLOSE
CHG
CHG%
$2.25
-0.06
-0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 05-09-2024 | 08-13-2024 | 11-14-2024 | |
| Total revenue | 145.880 K | 136.431 K | 80.380 K | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | |
| Gross profit | 145.880 K | 136.431 K | 80.380 K | |
| -6.48% | -41.08% | |||
| Operating expenses | 1.364 M | 1.089 M | 1.540 M | |
| Selling general and admin | 520.926 K | 427.062 K | 493.102 K | |
| Research and development | 842.600 K | 661.558 K | 1.047 M | |
| Total expenses | 1.364 M | 1.089 M | 1.540 M | |
| -20.16% | 41.44% | |||
| Operating income | -1.218 M | -952.189 K | -1.459 M | |
| Ebit | -1.218 M | -952.189 K | -1.459 M | |
| Pretax income | -1.192 M | -938.146 K | -1.445 M | |
| -21.28% | 53.99% | |||
| Income tax | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | |
| Net income | -1.192 M | -938.146 K | -1.445 M | |
| 21.28% | -53.99% |
